ACC GUIDELINES Bundle (free trial)

UA/NSTEMI (ACC)

ACC GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/244063

Contents of this Issue

Navigation

Page 28 of 49

Initial Conservative Versus Initial Invasive Strategies ÎÎAn early invasive strategy (ie, diagnostic angiography with intent to perform revascularization) is indicated in UA/NSTEMI patients who have refractory angina or hemodynamic or electrical instability (without serious comorbidities or contraindications to such procedures). (I-B) ÎÎAn early invasive strategy (ie, diagnostic angiography with intent to perform revascularization) is indicated in initially stabilized UA/NSTEMI patients (without serious comorbidities or contraindications to such procedures) who have an elevated risk for clinical events. (I-A) ÎÎIt is reasonable to choose an early invasive strategy (within 12-24 h of admission) over a delayed invasive strategy for initially stabilized highrisk patients with UA/NSTEMI. For patients not at high risk, a delayed invasive approach is also reasonable. (IIa-B) Immediate catheterization/angiography is recommended for unstable patients. ÎÎIn initially stabilized patients, an initially conservative (ie, a selectively invasive) strategy may be considered as a treatment strategy for UA/NSTEMI patients (without serious comorbidities or contraindications to such procedures) who have an elevated risk for clinical events, including those who are troponin positive. (IIb-B) The decision to implement an initial conservative (vs initial invasive) strategy in these patients may be made by considering physician and patient preference. (IIb-C) ÎÎAn early invasive strategy (ie, diagnostic angiography with intent to perform revascularization) is NOT recommended in patients with extensive comorbidities (eg, liver or pulmonary failure, cancer), in whom the risks of revascularization and comorbid conditions are likely to outweigh the benefits of revascularization. (III: No Benefit-C) ÎÎAn early invasive strategy (ie, diagnostic angiography with intent to perform revascularization) is NOT recommended in patients with acute chest pain and a low likelihood of ACS. (III: No Benefit-C) ÎÎAn early invasive strategy (ie, diagnostic angiography with intent to perform revascularization) should NOT be performed in patients who will not consent to revascularization regardless of the findings. (III: No Benefit-C) 27

Articles in this issue

Archives of this issue

view archives of ACC GUIDELINES Bundle (free trial) - UA/NSTEMI (ACC)